Jubilant-Endo meet early stage milestone in oncology deal
This article was originally published in Scrip
Executive Summary
Jubilant Biosys, a subsidiary of India's Jubilant Organosys, and Endo Pharmaceuticals of the US have met an early stage milestone in one of the collaborative programmes.